CD8A and Huntington disease: As a result, the CD4:CD8 ratios were significantly higher in severe patients than in the healthy donors (6.7 ± 1.3 in COVID-19 vs. 2.5 ± 0.3 in HD, P=0.0226) (Figure 3B and Table S2).